*OT much ado about nothing
Oh, I might have guessed that any TA on
the chart of Ariad would generate a sell,
no surprise there, but thanks for the link.
Selling at the bottom does not seem like a
good idea, and I should think that if I were
really deluded on this one, somebody might have
PMed me by now with a warning. The comment
"I say away from convertibles" is not sufficient
reason for me to stay away from Ariad, and if the
toxic continues to punish and allow me to
accumulate shares, so be it. We cannot be sure
the biogurus are completely genuine in their
comments--for all I know they would like to
talk it down, or more likely, a few folks were
able to get sufficient gains out of the January
Science/EPO spike to pay for shares that have
been placed on the back burner.
I should probably move on and play with something
that seems to have a little interest--as I said,
CEGE looks good, TRGNY seems rather cheap, I should
use the time I spend whining about Ariad to sort
through some of the other seemingly cheap stocks in
this beaten down sector--what about GENE, GLGC, CRGN,
dont know, have not persued these older ideas as
much as I could.
I do like to pull up the detailed quotes for my GT
watch list, just to see the charts and remind me
of the marketcaps. I have a general idea which
companies are likely to disappoint in the short
term and see their marketcap whacked, and which
simply cannot go too much lower and are more
likely to see an upward spike on any good news.
I would like to be in the mode where I had a batch
(of aria) which had been paid for...instead of embarrassing
myself as I run from thread to thread tugging at
biogurus' shirtsleeves for attention on this one.
And for sure, my notion that somehow ARGENT can be
paired with various CTL therapies and will evolve
into a very broad, valuable platform is not a very
educated guess. It is a guess only marginally better
than the guess you make in Vegas as you sip on your
free drink, and tell the dealer--Hit Me. |
